Home
Disease Knowledge Center Drug Hub Monographs Drug Interactions Pregnancy Drug Safety Drug Recalls & Alerts OTC Navigator
Virtual Simulators Hub Clinical Cases Simulator Nutrition & Macro Calculator
Questo Insights Global Opportunities Hub AI Research Assistant Citation & Reference Generator Scholarships & Essay Planner Visa & Mobility Navigator English Assessment Test
Verified Jobs Board Pharmacy Clearance Pharmacies Directory
Practice Quizzes STEM Academy Toolkits
Medical Case Donations Opportunity Crowdfunding Community Forums Courses Academy
Back to Safety Checker

Acetaminophen

Non-Opioid Analgesic & Antipyretic

FDA Category B (No Fetal Risk in Human/Animal Studies) FDA Category B & Strong Evidence
Safe — Preferred Analgesic & Antipyretic

Acetaminophen (Paracetamol) is the first-line, safest choice for treating fever and pain throughout all trimesters of pregnancy when used at the lowest effective dose for the shortest duration.

Medical Disclaimer: This report is for educational and informational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making any medication decisions during pregnancy.
Pregnancy Summary
Clinical overview for pregnancy

Acetaminophen is widely recognized by ACOG and FDA as the safest fever reducer and pain reliever during pregnancy. Treating maternal fever above 38.5°C is crucial to prevent fever-induced neural tube defects.

Trimester Safety Timeline
Safety profile across all three trimesters
1st Trimester
Weeks 1 – 12
Safe — Preferred

First-line agent for maternal fever reduction. Maternal hyperthermia (>38.5°C) poses a far greater teratogenic risk than acetaminophen.

2nd Trimester
Weeks 13 – 27
Safe

Safe for acute pain management. Use lowest effective therapeutic dose.

3rd Trimester
Weeks 28 – Birth
Safe

Safe. Does not cause premature closure of the fetal ductus arteriosus (unlike NSAIDs).

Placental Transfer
Does this medication cross the placenta?
Crosses Placenta
Yes
Transfer Extent
High (Rapidly crosses placental barrier via passive diffusion)

Umbilical cord blood concentrations equal maternal serum levels. Fetal liver metabolizes it via sulfation safely at therapeutic doses.

Fetal Risk Assessment
Potential effects on the developing fetus
No Major Teratogenic Risk

Large prospective cohort studies (>100,000 pregnancies) demonstrate no elevated risk of major structural congenital malformations.

Maternal Risk Assessment
Potential maternal side effects during pregnancy
Hepatotoxicity (Overdose Only)

Extremely safe at standard doses (max 3,000 mg/day in pregnancy). Doses exceeding max thresholds risk acute liver injury.

Clinical Recommendation
Professional prescribing guidance
Generally Preferred — First Choice

First-line choice for fever and pain in pregnant patients. Limit dose to <= 3,000 mg/day and restrict to shortest duration necessary.

If Already Taken
"I took this before knowing I was pregnant"
1
Reassurance

Taking therapeutic doses of acetaminophen carries minimal risk to the fetus. No emergency action required.

Pregnancy Monitoring Protocol
Recommended follow-up and surveillance
Maternal Surveillance
  • Track cumulative daily dosage
  • Avoid multi-ingredient cold remedies containing decongestants
Safer Alternatives
Active ingredients with better pregnancy safety profiles
paracetamol
Identical active ingredient (International Nonproprietary Name).
Safe
Professional Clinical Notes
Key prescribing considerations and clinical pearls
  • Treating maternal hyperthermia (> 38.5°C) during organogenesis is essential to prevent neural tube defects.
Patient-Friendly Explanation
In simple, easy-to-understand language
Easy to Understand

Acetaminophen (Paracetamol) is the safest pain and fever medicine to take during pregnancy.

Frequently Asked Questions
Common questions about Acetaminophen in pregnancy

Yes. Acetaminophen is the preferred pain reliever and fever reducer during the first trimester.

Evidence Level
Quality of available safety data
FDA Category B & Strong Evidence

Backed by extensive global observational registries and ACOG guidelines.

References & Primary Sources
Official U.S. Food & Drug Administration (FDA) PLLR & ACOG Clinical Database
All pregnancy safety evaluations, risk categories, and drug monographs are compiled directly from U.S. FDA Pregnancy and Lactation Labeling Rule (PLLR) standards and approved FDA prescribing labels.
  1. 1
    U.S. Food and Drug Administration (FDA) PLLR — FDA Pregnancy and Lactation Labeling Rule & Approved Prescribing Information Database Last updated: Official FDA Standard
  2. 2
    FDA Center for Drug Evaluation and Research (CDER) — FDA MedWatch & Black Box Warning Database Last updated: Official FDA Standard
  3. 3
    ACOG Practice Bulletins & Guidelines — American College of Obstetricians and Gynecologists Clinical Recommendations Last updated: 2025 Clinical Edition
  4. 4
    Briggs Drugs in Pregnancy and Lactation — Reference Guide to Fetal and Neonatal Risk (12th Edition) Last updated: 2025 Clinical Edition
Search Another Medication

System Notice

Confirm Action